Find Lapatinib Ditosylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 388082-77-7, Tykerb, Tykerb ditosylate, Lapatinib (gw-572016) ditosylate, Tyverb, Lapatinib (ditosylate)
Molecular Formula
C43H42ClFN4O10S3
Molecular Weight
925.5  g/mol
InChI Key
UWYXLGUQQFPJRI-UHFFFAOYSA-N
FDA UNII
4WK72K94MC

Lapatinib Ditosylate
A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
1 2D Structure

Lapatinib Ditosylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid
2.1.2 InChI
InChI=1S/C29H26ClFN4O4S.2C7H8O3S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10)
2.1.3 InChI Key
UWYXLGUQQFPJRI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
2.2 Other Identifiers
2.2.1 UNII
4WK72K94MC
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gw 282974x

2. Gw 572016

3. Gw-282974x

4. Gw-572016

5. Gw282974x

6. Gw572016

7. Lapatinib

8. N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine

9. Tykerb

2.3.2 Depositor-Supplied Synonyms

1. 388082-77-7

2. Tykerb

3. Tykerb Ditosylate

4. Lapatinib (gw-572016) Ditosylate

5. Tyverb

6. Lapatinib (ditosylate)

7. N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine Bis(4-methylbenzenesulfonate)

8. 388082-78-8

9. Lapatinib Ditosylate Anhydrous

10. 4wk72k94mc

11. 388082-77-7 (ditosylate)

12. Bis(4-methylbenzene-1-sulfonic Acid); N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine

13. Gw-572016

14. 4-quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-, Bis(4-methylbenzenesulfonate)

15. N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine Ditosylate

16. Sr-05000001472

17. N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic Acid

18. S1028

19. Unii-4wk72k94mc

20. Gw 572016f

21. Gw-572016 Ditosylate

22. Lapatinib Ditosylate,tykerb

23. Schembl93590

24. Quinazolin-4-amine Ditosylate

25. Chembl1201183

26. Dtxsid60959606

27. Hms3265i13

28. Hms3265i14

29. Hms3265j13

30. Hms3265j14

31. Hms3654e07

32. Hy-50898a

33. Mfcd09264195

34. Akos015888607

35. Ac-5247

36. Ccg-264661

37. Cs-0831

38. Gs-3661

39. Db-119273

40. Ft-0670728

41. Lapatinib Ditoluenesulfonate Anhydrous

42. Sw199101-4

43. Ec-000.2339

44. Lapatinib Ditosylate Anhydrous [who-dd]

45. Gw 572016 Ditosylate;gw-572016 Ditosylate

46. Lapatinib Ditoluenesulfonate Anhydrous [mi]

47. Sr-05000001472-2

48. Sr-05000001472-5

49. Q27260601

50. Z1692482592

51. 4-methylbenzene-1-sulfonic Acid--n-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine (2/1)

52. 4-quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-, 4-methylbenzenesulfonate (1:2)

53. N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine Bis(4-methylbenzenesulfona

54. N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl) Ethylamino)methyl)furan-2-yl)quinazolin-4-amine Ditosylate

55. N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine Ditosylate

56. N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 925.5 g/mol
Molecular Formula C43H42ClFN4O10S3
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count15
Rotatable Bond Count13
Exact Mass924.1735629 g/mol
Monoisotopic Mass924.1735629 g/mol
Topological Polar Surface Area240 Ų
Heavy Atom Count62
Formal Charge0
Complexity1100
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameTykerb
PubMed HealthLapatinib (By mouth)
Drug ClassesAntineoplastic Agent
Drug LabelLapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt, with chemical name N-(3-chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfony...
Active IngredientLapatinib ditosylate
Dosage FormTablet
RouteOral
Strengtheq 250mg base
Market StatusPrescription
CompanySmithkline Beecham

2 of 2  
Drug NameTykerb
PubMed HealthLapatinib (By mouth)
Drug ClassesAntineoplastic Agent
Drug LabelLapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt, with chemical name N-(3-chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfony...
Active IngredientLapatinib ditosylate
Dosage FormTablet
RouteOral
Strengtheq 250mg base
Market StatusPrescription
CompanySmithkline Beecham

4.2 Drug Indication

Tyverb is indicated for the treatment of patients with breast cancer , whose tumours overexpress HER2 (ErbB2):

- in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting;

- in combination with trastuzumab for patients with hormone-receptor-negative metastatic disease that has progressed on prior trastuzumab therapy or therapies in combination with chemotherapy;

- in combination with an aromatase inhibitor for post-menopausal women with hormone-receptor-positive metastatic disease, not currently intended for chemotherapy. The patients in the registration study had not previously been treated with trastuzumab or an aromatase inhibitor. No data are available on the efficacy of this combination relative to trastuzumab in combination with an aromatase inhibitor in this patient population.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


5.2 ATC Code

L01EH01


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

LAPATINIB DITOSYLATE

NDC Package Code : 62207-980

Start Marketing Date : 2023-07-12

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Granules India

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 33656-0014

Start Marketing Date : 2020-04-14

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 59116-4480

Start Marketing Date : 2014-08-08

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 48087-0095

Start Marketing Date : 2010-12-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 68554-0072

Start Marketing Date : 2007-03-13

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 54893-0110

Start Marketing Date : 2021-02-27

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 63850-7421

Start Marketing Date : 2021-05-17

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB

NDC Package Code : 61187-009

Start Marketing Date : 2014-09-11

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE ANHYDROUS

NDC Package Code : 87072-0001

Start Marketing Date : 2025-09-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

SciAnda(Changshu) Pharmaceuticals, ...

Country
PEGS Boston Summit
Not Confirmed
arrow

SciAnda(Changshu) Pharmaceuticals, ...

Country
arrow
PEGS Boston Summit
Not Confirmed

LAPATINIB DITOSYLATE

NDC Package Code : 54245-7005

Start Marketing Date : 2015-01-05

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships fo...

ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships for product development, compliance, and secure logistics. ChemWerth accesses over 500 APIs and 30 manufacturing facilities across the US, Europe, India, and China, acts as a regulatory agent for 25+ FDA-approved facilities, sells 100+ products, and operates in 38 countries. In 2020, it filed its 500th DMF with the FDA . Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Chemwerth Compnay Banner

02

Minakem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical and regulatory service...

MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical and regulatory services, excel in process development and organic synthesis, operating under secrecy agreements to protect client IP. With three European and one Canadian production site, MINAKEM supports strategic sourcing and reshoring projects. Recently launched commercial generic APIs include Apixaban, Mirabegron, Fulvestrant, remifentanil, and esmolol. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Minakem Comapny Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...

Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our employees operate a regularly inspected cGMP facility equipped with reactors ranging from 40 to 7,600 litres. Located in Montreal, Canada, we have contributed to the success of our North-American and international clients since 1964.
Minakem Delmar

04

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothIKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Flag France
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development ...

Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development of raw materials for pharmaceutical and cosmetic industries, supplying Europe, Japan, and beyond. With expertise in fine chemicals, it manufactures from pilot to commercial scale at its GMP-certified facility in St. Pierre-Les-Elbeuf, France. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Inabata Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered i...

Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered in Hauppauge, New York, it operates 16 offices worldwide. Rochem’s operations are fully cGMP compliant and have been audited by the USFDA and several multinational organizations. The company also trains and audits its partners to ensure FDA-compliant technologies and systems. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Rochem

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...

Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Shanghai Minbiotech CB

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content

Lapatinib Ditosylate

About the Company : Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufac...

Sumar Biotech LLP, registered in January 2018, is a startup approved by the Gujarat State Biotechnology Mission. Founded by young entrepreneurs and experienced research and manufacturing professionals, the company focuses on innovating and manufacturing semi-synthetic, synthetic, and fermentation-based APIs. Its R&D facility is equipped with advanced technology for synthesis, extraction, isolation, purification, and upstream fermentation, with active work in process chemistry for therapeutic molecules. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Sumar Biotech

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.

Flag India
Digital Content Digital Content

Lapatinib

About the Company : Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs a...

Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs and High Potency APIs, adhering to the highest global quality and compliance standards. As a fully integrated company, Cerata supports the complete API lifecycle from development to commercialization. Our products are trusted by pharmaceutical companies in over 40 countries, reflecting our strong global presence and commitment to excellence. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Lapatinib Ditosylate

About the Company : JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao I...

JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao International airport. JIN DUN Medical Research Institute is committed to providing pharmaceutical intermediates and raw materials with the purpose of innovative drug research. Customized R&D and customized production services.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMalladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

CAS Number : 202197-26-0

End Use API : Lapatinib Ditosylate

About The Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top AP...

Malladi

02

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 1885-29-6

End Use API : Lapatinib Ditosylate

About The Company : Established in 1975, Acharya Group is a trusted and well-established chemical manufacturing company renowned for its commitment to technological excellence. Ach...

blank

03

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 1885-29-6

End Use API : Lapatinib Ditosylate

About The Company : Corey Organics is focused in developing and manufacturing of Active Pharmaceutical Ingredients (APIs), registered Pharma Intermediates, Fine Chemicals and Pyrid...

blank

04

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 4637-24-5

End Use API : Lapatinib Ditosylate

About The Company : Darshan Pharmachem, founded in 2011 in Ankleshwar, is a leading pharmaceutical company specializing in high-quality and innovative API intermediates. We are com...

blank

05

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 27329-70-0

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

06

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 231278-20-9

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

07

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 104458-24-4

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

08

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 231278-84-5

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

09

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 202197-26-0

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

10

PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed
arrow

CAS Number : 231278-20-9

End Use API : Lapatinib Ditosylate

About The Company : Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shanghai is only 1.5 hours by car. Established in 2006, we hav...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 388082-77-7 / Lapatinib Ditosylate API manufacturers, exporters & distributors?

Lapatinib Ditosylate manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Lapatinib Ditosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lapatinib Ditosylate manufacturer or Lapatinib Ditosylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lapatinib Ditosylate manufacturer or Lapatinib Ditosylate supplier.

API | Excipient name

Lapatinib Ditosylate

Synonyms

388082-77-7, Tykerb, Tykerb ditosylate, Lapatinib (gw-572016) ditosylate, Tyverb, Lapatinib (ditosylate)

Cas Number

388082-77-7

Unique Ingredient Identifier (UNII)

4WK72K94MC

About Lapatinib Ditosylate

A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.

Lapatinib Ditosylate,Tykerb Manufacturers

A Lapatinib Ditosylate,Tykerb manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lapatinib Ditosylate,Tykerb, including repackagers and relabelers. The FDA regulates Lapatinib Ditosylate,Tykerb manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lapatinib Ditosylate,Tykerb API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Lapatinib Ditosylate,Tykerb manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Lapatinib Ditosylate,Tykerb Suppliers

A Lapatinib Ditosylate,Tykerb supplier is an individual or a company that provides Lapatinib Ditosylate,Tykerb active pharmaceutical ingredient (API) or Lapatinib Ditosylate,Tykerb finished formulations upon request. The Lapatinib Ditosylate,Tykerb suppliers may include Lapatinib Ditosylate,Tykerb API manufacturers, exporters, distributors and traders.

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Lapatinib Ditosylate,Tykerb USDMF

A Lapatinib Ditosylate,Tykerb DMF (Drug Master File) is a document detailing the whole manufacturing process of Lapatinib Ditosylate,Tykerb active pharmaceutical ingredient (API) in detail. Different forms of Lapatinib Ditosylate,Tykerb DMFs exist exist since differing nations have different regulations, such as Lapatinib Ditosylate,Tykerb USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Lapatinib Ditosylate,Tykerb DMF submitted to regulatory agencies in the US is known as a USDMF. Lapatinib Ditosylate,Tykerb USDMF includes data on Lapatinib Ditosylate,Tykerb's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lapatinib Ditosylate,Tykerb USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with USDMF on PharmaCompass.

Lapatinib Ditosylate,Tykerb JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Lapatinib Ditosylate,Tykerb Drug Master File in Japan (Lapatinib Ditosylate,Tykerb JDMF) empowers Lapatinib Ditosylate,Tykerb API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Lapatinib Ditosylate,Tykerb JDMF during the approval evaluation for pharmaceutical products. At the time of Lapatinib Ditosylate,Tykerb JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with JDMF on PharmaCompass.

Lapatinib Ditosylate,Tykerb KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Lapatinib Ditosylate,Tykerb Drug Master File in Korea (Lapatinib Ditosylate,Tykerb KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lapatinib Ditosylate,Tykerb. The MFDS reviews the Lapatinib Ditosylate,Tykerb KDMF as part of the drug registration process and uses the information provided in the Lapatinib Ditosylate,Tykerb KDMF to evaluate the safety and efficacy of the drug.

After submitting a Lapatinib Ditosylate,Tykerb KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lapatinib Ditosylate,Tykerb API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with KDMF on PharmaCompass.

Lapatinib Ditosylate,Tykerb WC

A Lapatinib Ditosylate,Tykerb written confirmation (Lapatinib Ditosylate,Tykerb WC) is an official document issued by a regulatory agency to a Lapatinib Ditosylate,Tykerb manufacturer, verifying that the manufacturing facility of a Lapatinib Ditosylate,Tykerb active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lapatinib Ditosylate,Tykerb APIs or Lapatinib Ditosylate,Tykerb finished pharmaceutical products to another nation, regulatory agencies frequently require a Lapatinib Ditosylate,Tykerb WC (written confirmation) as part of the regulatory process.

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with Written Confirmation (WC) on PharmaCompass.

Lapatinib Ditosylate,Tykerb NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lapatinib Ditosylate,Tykerb as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Lapatinib Ditosylate,Tykerb API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Lapatinib Ditosylate,Tykerb as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Lapatinib Ditosylate,Tykerb and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lapatinib Ditosylate,Tykerb NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Lapatinib Ditosylate,Tykerb suppliers with NDC on PharmaCompass.

Lapatinib Ditosylate,Tykerb GMP

Lapatinib Ditosylate,Tykerb Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Lapatinib Ditosylate,Tykerb GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lapatinib Ditosylate,Tykerb GMP manufacturer or Lapatinib Ditosylate,Tykerb GMP API supplier for your needs.

Lapatinib Ditosylate,Tykerb CoA

A Lapatinib Ditosylate,Tykerb CoA (Certificate of Analysis) is a formal document that attests to Lapatinib Ditosylate,Tykerb's compliance with Lapatinib Ditosylate,Tykerb specifications and serves as a tool for batch-level quality control.

Lapatinib Ditosylate,Tykerb CoA mostly includes findings from lab analyses of a specific batch. For each Lapatinib Ditosylate,Tykerb CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Lapatinib Ditosylate,Tykerb may be tested according to a variety of international standards, such as European Pharmacopoeia (Lapatinib Ditosylate,Tykerb EP), Lapatinib Ditosylate,Tykerb JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lapatinib Ditosylate,Tykerb USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty